Hdl Handle:
http://hdl.handle.net/10147/125153
Title:
Palivizumab use in preterm neonates.
Authors:
Kingston, S; Murphy, B P
Affiliation:
Department of Neonatology, Cork University Maternity Hospital, Wilton, Cork.
Citation:
Palivizumab use in preterm neonates. 2010, 103 (5):141-4 Ir Med J
Journal:
Irish medical journal
Issue Date:
May-2010
URI:
http://hdl.handle.net/10147/125153
PubMed ID:
20666085
Abstract:
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis in infants. Palivizumab is an immunoprophylactic agent for RSV prevention in preterm infants and those with neonatal chronic lung disease. This study examines its use across neonatal units in Ireland. A questionnaire was administered to one Consultant Neonatologist or Paediatrician in each of the 20 maternity centres in Ireland about their guidelines for Palivizumab administration. There is variation in administration of Palivizumab with little consistency found between protocols reported in terms of age and presence of chronic lung disease. Ten centres have in house protocols, 3 centres use the American Academy of Paediatrics (AAP) guidelines, 2 centres prefer the UK Joint Committee on Vaccination and Immunisation (JCVI) guidelines and 3 centres do not have a set protocol. Four participants felt its use has impacted on hospital admissions and 61% believe its use is cost effective. The budgetary implication for immunoprophylaxis with Palivizumab in Ireland is estimated at 1.5 to 2 million euros annually. Given current pharmacoeconomic constraints there is a need to implement a national protocol on RSV immunoprophylaxis.
Item Type:
Article
Language:
en
MeSH:
Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis; Clinical Protocols; Female; Guideline Adherence; Humans; Infant, Newborn; Infant, Premature; Ireland; Male; Physician's Practice Patterns; Questionnaires; Respiratory Syncytial Virus Infections
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorKingston, Sen
dc.contributor.authorMurphy, B Pen
dc.date.accessioned2011-03-21T12:23:19Z-
dc.date.available2011-03-21T12:23:19Z-
dc.date.issued2010-05-
dc.identifier.citationPalivizumab use in preterm neonates. 2010, 103 (5):141-4 Ir Med Jen
dc.identifier.issn0332-3102-
dc.identifier.pmid20666085-
dc.identifier.urihttp://hdl.handle.net/10147/125153-
dc.description.abstractRespiratory syncytial virus (RSV) is the leading cause of bronchiolitis in infants. Palivizumab is an immunoprophylactic agent for RSV prevention in preterm infants and those with neonatal chronic lung disease. This study examines its use across neonatal units in Ireland. A questionnaire was administered to one Consultant Neonatologist or Paediatrician in each of the 20 maternity centres in Ireland about their guidelines for Palivizumab administration. There is variation in administration of Palivizumab with little consistency found between protocols reported in terms of age and presence of chronic lung disease. Ten centres have in house protocols, 3 centres use the American Academy of Paediatrics (AAP) guidelines, 2 centres prefer the UK Joint Committee on Vaccination and Immunisation (JCVI) guidelines and 3 centres do not have a set protocol. Four participants felt its use has impacted on hospital admissions and 61% believe its use is cost effective. The budgetary implication for immunoprophylaxis with Palivizumab in Ireland is estimated at 1.5 to 2 million euros annually. Given current pharmacoeconomic constraints there is a need to implement a national protocol on RSV immunoprophylaxis.-
dc.language.isoenen
dc.subject.meshAntibodies, Monoclonal-
dc.subject.meshAntiviral Agents-
dc.subject.meshBronchiolitis-
dc.subject.meshClinical Protocols-
dc.subject.meshFemale-
dc.subject.meshGuideline Adherence-
dc.subject.meshHumans-
dc.subject.meshInfant, Newborn-
dc.subject.meshInfant, Premature-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshPhysician's Practice Patterns-
dc.subject.meshQuestionnaires-
dc.subject.meshRespiratory Syncytial Virus Infections-
dc.titlePalivizumab use in preterm neonates.en
dc.typeArticleen
dc.contributor.departmentDepartment of Neonatology, Cork University Maternity Hospital, Wilton, Cork.en
dc.identifier.journalIrish medical journalen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.